Challenges of Managing Chronic Peritoneal Dialysis-Associated Peritonitis

Burkart J. , Schreiber M. , Tabor T. , Korbet S. , Stallard R , and PD Collaborative Group. Prospective, multicenter evaluation of patient transfer from PD to HD in 1995 (Abstract). Perit Dial Int 1996; 16(Suppl 2): S66.

Fried L F. , Bernardini J. , Johnston J.R. , Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176–82.

Gorban–Brennan N. , Troidle L. , Kliger A. , Finkelstein F.O. Peritonitis and its relationship with death in a large CPD cohort (Abstract). Perit Dial Int 1999; 19(Suppl 1): S31.

Ad Hoc Advisory Committee on Peritonitis Management Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int 1993; 13: 14–28.

Vas S. Treatment of peritonitis. Perit Dial Int 1994; 14(Suppl 3): S49–55.

Troidle L. , Kliger A.S. , Gorban–Brennan N. , Fikrig M. , Golden M. , Finkelstein F.O. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney Int 1996; 50: 1368–72.

Carey H.B. , Troidle L. , Kliger A.S. , Finkelstein F.O. VRE peritonitis: a case report and review of the literature. Semin Dial 1999; (in press).

Frieden T.R. , Munsiff S.S. , Low D.E. , Willey B.M. , Williams G. , Faur Y. Emergence of vancomycin resistant enterococci in New York City. Lancet 1993; 342: 76–9.

Hospital Infection Control Practices Advisory Committee (HICPAC) Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105–13.

Noble W.C. , Virani Z. , Cree R.G.A. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195–8.

Smith T.L. , Pearson M.L. , Wilcox K.R. , Cruz C. , Lancaster M.V. , Robinson–Dunn B. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 316: 927–31.

Keane W F. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16: 557–73.

Lai M-N , Kao M-T , Chen C-C , Cheung S-Y , Chung W-K Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 1997; 17: 87–9.

Brown E.A. , Goldberg L.C. , Clemenger M. , Azadian B. Effective treatment of peritonitis using a once-daily, vancomycin-free regime in CAPD and APD (Abstract). Perit Dial Int 1999; 19(Suppl 1): S30.

Vas S. , Bargman J. , Oreopoulos D.G. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17: 91–4.

Troidle L.K. , Gorban–Brennan N. , Kliger A.S. , Finkelstein F.O. Peritonitis in the extended care facility. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1998; 14: 127–30.

Hashimoto H. , Inoue M. , Hayashi I. A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993. Jpn J Antibiot 1994; 47: 618–26.

Jorgensen J.H. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed, Approved standard. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.

Manley H.J. , Bailie G. , Asher R.D. , Eisele G. , Frye R. F. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19: 65–70.

Rahal J.J. , Urban C. , Horn D. , Freeman K. , Segal–Maurer S. , Maurer J. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233–7.

Held P.J. , Port F.K. , Webb R.L. USRDS 1997 annual data report: treatment modalities for ESRD patients. Am J Kidney Dis 1997; 30(Suppl 1): S54–66.

Troidle L.K. , Gorban–Brennan N. , Kliger A.S. , Finkelstein F.O. Continuous cycler therapy, manual peritoneal dialysis therapy, and peritonitis. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1998; 14: 137–41.

Schmidt R. , Bender F. , Domico J. , Bernardini J. , Sorkin M. , Piraino B. Peritonitis rates of APD may not better those of CAPD (Abstract). Perit Dial Int 1998; 18(Suppl 1): S34.

Bunke C.M. , Brier M.E. , Golper T. Outcomes of singleorganism peritonitis in peritoneal dialysis: gram-negatives versus gram-positives in the Network 9 peritonitis study. Kidney Int 1997; 52: 524–9.

Troidle L. , Gorban–Brennan N.L.R. , Kliger A. , Finkelstein F.O. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32: 623–8.

Troidle L.K. , Kliger A.S. , Goldie S.J. , Gorban–Brennan N. , Finkelstein F.O. CPD-associated peritonitis of nosocomial origin. Perit Dial Int 1996; 16: 505–10.

Wiener J. , Quinn J.P. , Bradford P.A. , Goering R.V. , Nathan C. , Bush K. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517–23.

Lakaye B. , Dubus A. , Lepage S. , Groslambert S. , Frere J-M When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with beta-lactams. Mol Microbiol 1999; 31: 89–101.

Juergensen P. , Finkelstein F. , Brennan R. , Kliger A. Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six year study. Am J Kidney Dis 1988; 11: 1413–17.

Luzar M.A. , Coles G. , Faller B. , Slingeneyer A. , Dah Dah G. , Briat C. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322: 505–9.

Piraino B. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 1990; 16: 89–95.

Bernardini J. , Piraino B. , Holley J. , Johnston J.R. , Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27: 695–700.

Thodis E. , Bhaskaran S. , Pasadakis P. , Bargman J.M. , Vas S.I. , Oreopoulos D.G. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261–70.

Goldie S.J. , Kiernan–Troidle L. , Torres C. , Gorban–Brennan N. , Dunne D. , Kliger A.S. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86–91.

Lo W-K , Chan C-Y , Cheng S-W , Poon JF-M , Chan DT-M , Cheng IK-P A prospective randomized control study of oral nystatin prophylaxis for candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.

Thodis E. , Vas S.I. , Bargman J.M. , Singhal M. , Chu M. , Oreopoulos D.G. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 583–9.